(Press-News.org) Contact information: Rafael Roesler
rafael.roesler@pq.cnpq.br
55-513-359-7616
Write Science Right
Helping good genes win in brain cancer cells
Porto Alegre, Brazil - Researchers at the Federal University of Rio Grande do Sul (UFRGS), the university hospital (Hospital de Clínicas de Porto Alegre, HCPA) and the Children's Cancer Institute (Instituto do Câncer Infantil do Rio Grande do Sul, ICI-RS) in Porto Alegre, Brazil, have shown that manipulating an epigenetic mechanism, which regulates gene expression, may promote cell death and favor maturation towards less malignant-prone phenotypes in pediatric brain cancer cell lines.
Cancer cells show alterations in gene expression related to modifications in the state of their chromatin, the "package" containing the genes in the cell nucleus. A group of enzymes called histone deacetylases (HDACs) helps to organize DNA within the cell nucleus by keeping chromatin in a more condensed state, thus inhibiting gene expression. The HDAC system is one component in the set of epigenetic mechanisms that regulate gene readout. There is growing interest in investigating compounds that inhibit HDACs, thereby allowing chromatin relaxation and increased gene expression, as candidate anticancer drugs.
Medulloblastoma is the most common type of childhood brain cancer. Although cure rates have improved, about 30% of patients with medulloblastoma tumors still have a low chance of being cured and survivors often experience long-term neurocognitive and neuroendocrine impairments.
In a study published in the December 2013 issue of the journal Molecular Neurobiology, Carolina Nör and colleagues – namely, study leader Rafael Roesler, ICI-RS researchers Caroline Brunetto de Farias, Ana Lucia Abujamra, and Algemir Lunardi Brunetto, and UFRGS and HCPA researchers Gilberto Schwartsmann, Felipe A. Sassi, and Guido Lenz - showed that sodium butyrate, a drug that acts on epigenetic regulation by inhibiting HDACs, reduces the survival of cultured medulloblastoma cells as well as formation of neurospheres in the cell cultures, which may indicate inhibition of cancer stem cell proliferation. In addition, cells treated with sodium butyrate showed enhanced mRNA expression of a marker of differentiation towards a mature neuronal phenotype. Finally, sodium butyrate enhanced the anticancer effect of the chemotherapeutic drug etoposide. These findings support and extend previous evidence indicating that HDAC inhibitors can reduce brain tumor growth by allowing genes involved in the promotion of cell death and maturation to be expressed.
"The use of HDAC inhibitors is currently the most important pharmacological approach to manipulate the epigenome. We are using cultured human brain tumor cell lines to identify novel effects of HDAC inhibitors. Although these findings need to be confirmed by in vivo experiments as well as by studies using cancer cells obtained directly from patients, our results support the view that these agents can allow the expression of genes related to cell death, or those involved in differentiation of tumor cells into mature brain cell types, hence having anticancer effects", says Roesler.
In addition to public research funding organizations, including the National Council for Scientific and Technological Development (CNPq) and the National Institute for Translational Medicine (INCT-TM), major support for the study was provided by the Rafael Koff Acordi Project, a research fund created by the Koff Acordi family in partnership with ICI-RS. "It is still uncommon to see basic cancer research being supported by private donations in Brazil, and we are working to promote this type of initiative", says Remi Acordi. "Our goal is to increasingly engage in basic research informed by clinical needs", says Algemir Brunetto, President of ICI-RS, a non-profit private organization focused on pediatric cancer treatment and research.
###
Article: Carolina Nör, Felipe A. Sassi, Caroline B. de Farias, Gilberto Schwartsmann, Ana Lucia Abujamra, Guido Lenz, Algemir L. Brunetto, Rafael Roesler. The histone deacetylase inhibitor sodium butyrate promotes cell death and differentiation and reduces neurosphere formation in human medulloblastoma cells. Molecular Neurobiology 2013, 48: 533-543.
Financial support: The study was supported by the National Council for Scientific and Technological Development (CNPq); the Rafael Koff Acordi Research Fund, Children's Cancer Institute (ICI-RS); the National Institute for Translational Medicine (INCT-TM); and the South American Office for Anticancer Drug Development (SOAD).
Helping good genes win in brain cancer cells
2013-12-20
ELSE PRESS RELEASES FROM THIS DATE:
Stanford and Google team up to simulate key drug receptor
2013-12-20
Stanford and Google team up to simulate key drug receptor
Roughly 40 percent of all medications act on cells' G protein-coupled receptors (GPCRs). One of these receptors, beta 2 adrenergic receptor site (B2AR), naturally transforms between two base configurations; knowing ...
UT Southwestern neuroscience researchers identify gene involved in response to cocaine
2013-12-20
UT Southwestern neuroscience researchers identify gene involved in response to cocaine
DALLAS – Dec. 19, 2013 – UT Southwestern neuroscience researchers have identified a gene that controls the response to cocaine by comparing closely related ...
ASU researchers develop new device to help image key proteins at room temperature
2013-12-20
ASU researchers develop new device to help image key proteins at room temperature
TEMPE, Ariz. – A group of researchers from Arizona State University are part of a larger team reporting a major advance in the study of human proteins that could open up new avenues ...
91 new species described by California Academy Of Sciences in 2013
2013-12-20
91 new species described by California Academy Of Sciences in 2013
SAN FRANCISCO (December 20, 2013) — In 2013, researchers at the California Academy of Sciences discovered 91 new plant and animal species and two new genera, enriching our understanding ...
JCI early table of contents for Dec. 20, 2013
2013-12-20
JCI early table of contents for Dec. 20, 2013
Fungal surface protein promotes host cell
Opportunistic infection of individuals on immunosuppressive therapy are a major problem for patient outcome, despite current prophylactic strategies. While the ability ...
Fungal surface protein promotes host cell
2013-12-20
Fungal surface protein promotes host cell
Opportunistic infection of individuals on immunosuppressive therapy are a major problem for patient outcome, despite current prophylactic strategies. While the ability to prevent infection with well-characterized ...
Angiogenic factor secretion by melanocytes associated with pigmentation leve
2013-12-20
Angiogenic factor secretion by melanocytes associated with pigmentation leve
The decreased vision loss that accompanies age-related macular degeneration (AMD) is associated with abnormal blood vessel growth in the eye. Frequencies of AMD development are ...
Nonsense suppression drug restores function in a mouse model of aniridia
2013-12-20
Nonsense suppression drug restores function in a mouse model of aniridia
Congenital aniridia is a progressive disease that is associated with improper development of eye structures as well as abnormalities in the brain and pancreas. A variety of nonsense ...
Dysfunctional TGF-beta signaling contributes to Loeys-Dietz syndrome-associated aortic aneurysm
2013-12-20
Dysfunctional TGF-beta signaling contributes to Loeys-Dietz syndrome-associated aortic aneurysm
Patients with the connective tissue disorder Loeys-Dietz syndrome (LDS) are at high risk for aortic aneurysm. LDS results in the presence of missense mutations ...
Evaluation of mangafodipir treatment for oxaliplatin-associated neuropathy
2013-12-20
Evaluation of mangafodipir treatment for oxaliplatin-associated neuropathy
An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, ...